Glenmark Life Sciences signs MSA with Japanese pharma company
To manufacture and supply API in the therapeutic area of urinary anti-spasmodic
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Glenmark Life Sciences
Glenmark to divest majority stake in Glenmark Life Sciences to Nirma
Nirma will acquire 75 per cent stake in Glenmark Life Sciences at a price of Rs 615/- per share